Scholar Rock Reports New Employee Grants Under Nasdaq Rule
12 Sep 2025 //
BUSINESSWIRE
Scholar Rock Announces New Inducement Grants Under Nasdaq Rule
15 Aug 2025 //
BUSINESSWIRE
Lancet Publishes Pivotal SAPPHIRE SMA Data for Apitegromab
14 Aug 2025 //
BUSINESSWIRE
Scholar Rock`s Q2 2025 Financial Results & Business Progress
06 Aug 2025 //
BUSINESSWIRE
Scholar Rock to Host Q2 Results Call on Aug 6, 2025
21 Jul 2025 //
BUSINESSWIRE
Scholar Rock Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
18 Jul 2025 //
BUSINESSWIRE
Scholar Rock to Present Update at 2025 Cure SMA Meeting
23 Jun 2025 //
BUSINESSWIRE
Scholar Rock`s Drug Helps Zepbound Patients Retain More Muscle
20 Jun 2025 //
REUTERS
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq
13 Jun 2025 //
BUSINESSWIRE
Scholar Rock at 46th Annual Goldman Sachs Healthcare Conference
05 Jun 2025 //
BUSINESSWIRE
Scholar Rock Appoints Rebecca McLeod as Brand Chief
02 Jun 2025 //
BUSINESSWIRE
Scholar Rock to Present at Jefferies Healthcare Conference
28 May 2025 //
BUSINESSWIRE
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq
16 May 2025 //
BUSINESSWIRE
Scholar Rock Reports Q1 2025 Financial Results & Business Progress
14 May 2025 //
BUSINESSWIRE
Scholar Rock to Discuss Q1 2025 Results and Business Update
07 May 2025 //
BUSINESSWIRE
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq
06 May 2025 //
BUSINESSWIRE
Scholar Rock Names David L. Hallal CEO; Adds Three Key Leaders
28 Apr 2025 //
BUSINESSWIRE
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq
18 Apr 2025 //
BUSINESSWIRE
FDA grants priority review for Apitegromab BLA, EMA accepts MAA
25 Mar 2025 //
BUSINESSWIRE
Scholar Rock Presents Phase 3 SAPPHIRE Data at 2025 Conference
16 Mar 2025 //
BUSINESSWIRE
Scholar Reports Employee Inducement Grants Under Nasdaq LR 5635(c)(4)
14 Mar 2025 //
BUSINESSWIRE
Scholar Rock Reports Full Year 2024 Financial Results & Progress
27 Feb 2025 //
BUSINESSWIRE
Scholar Rock to Participate in Upcoming Investor Conferences
25 Feb 2025 //
BUSINESSWIRE
Scholar Rock To Present Ph 3 SAPPHIRE Data At MDA 2025 Conference
21 Feb 2025 //
BUSINESSWIRE
Scholar Rock Reports Employee Grants Under Nasdaq LR 5635(c)(4)
14 Feb 2025 //
BUSINESSWIRE
Scholar Rock to Host Q4 and Full-Year 2024 Financial Results
10 Feb 2025 //
BUSINESSWIRE
Scholar Rock Appoints Lisa Wyman As Chief Technical Officer
29 Jan 2025 //
BUSINESSWIRE
Scholar Rock Submits BLA For Apitegromab In SMA
29 Jan 2025 //
BUSINESSWIRE
Scholar Report Employee Inducement Grants Under Nasdaq LR 5635©
17 Jan 2025 //
BUSINESSWIRE
Scholar Rock Highlights 2025 Strategic Priorities
08 Jan 2025 //
BUSINESSWIRE
Scholar Rock to Present at 43rd Annual J.P. Morgan Conference
02 Jan 2025 //
BUSINESSWIRE
Scholar Rock Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
13 Dec 2024 //
BUSINESSWIRE
Scholar Rock Announces Employee Inducement Grants Under Nasdaq Rule
15 Nov 2024 //
BUSINESSWIRE
Scholar Rock Reports Q3 2024 Financial Results & Business Progress
12 Nov 2024 //
BUSINESSWIRE
Scholar Rock to Participate in Upcoming Investor Conferences
31 Oct 2024 //
BUSINESSWIRE
Scholar Rock Closes Full Exercise Of Additional Shares Option
22 Oct 2024 //
BUSINESSWIRE
Scholar Rock Reports New Inducement Grants Under Nasdaq Rule
18 Oct 2024 //
BUSINESSWIRE
Scholar Rock Announces $300 Million Public Offering Pricing
08 Oct 2024 //
BUSINESSWIRE
Scholar Rock`s phase 3 SMA trial hits goal, catapulting stock up 327%
08 Oct 2024 //
FIERCE PHARMA
Scholar Rock Reports New Employee Inducement Grants
13 Sep 2024 //
BUSINESSWIRE
Scholar Rock Completes Apitegromab Phase 2 Enrollment
10 Sep 2024 //
BUSINESSWIRE
Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer
04 Sep 2024 //
BUSINESSWIRE
Scholar Rock to Participate in Upcoming Investor Conferences
29 Aug 2024 //
BUSINESSWIRE
Scholar Rock Reports Employee Inducement Grants Under Nasdaq Rule 5635(c)(4)
16 Aug 2024 //
BUSINESSWIRE
Scholar Rock Reports Q2 2024 Results And Business Progress
08 Aug 2024 //
BUSINESSWIRE
Scholar Rock To Report Q2 2024 Results On August 8
23 Jul 2024 //
BUSINESSWIRE
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Rules
12 Jul 2024 //
BUSINESSWIRE
Scholar Rock announces SRK-439 data on lean mass preservation
24 Jun 2024 //
BUSINESSWIRE
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Rule 5635(c)(4)
18 Jun 2024 //
BUSINESSWIRE
Scholar Rock`s SRK-181 DRAGON Phase 1 Data At ASCO 2024
03 Jun 2024 //
BUSINESSWIRE
Scholar Rock: DRAGON Trial Data On SRK-181 At ASCO 2024
28 May 2024 //
BUSINESSWIRE
Scholar Rock Begins Obesity Phase 2, Shows SRK-439 Preclinical Data
22 May 2024 //
BUSINESSWIRE
Scholar Rock to Participate in Upcoming Investor Conferences
20 May 2024 //
BUSINESSWIRE
Scholar Rock Reports New Employee Inducement Grants
17 May 2024 //
BUSINESSWIRE
Scholar Rock to Host Investor Day on May 22, 2024
14 May 2024 //
BUSINESSWIRE
Scholar Rock Q1 2024 Results, Business Highlights
07 May 2024 //
BUSINESSWIRE
Scholar Rock New Employee Grants Under Nasdaq 5635(c)(4)
12 Apr 2024 //
BUSINESSWIRE
Scholar Rock Reports Full Year 2023 Financial Results
19 Mar 2024 //
BUSINESSWIRE
Scholar Rock Reports Employee Inducement Grants Under Listing Rule 5635(c)(4)
15 Mar 2024 //
BUSINESSWIRE
Scholar Rock to Participate in Upcoming Investor Conferences
28 Feb 2024 //
BUSINESSWIRE